Molecular genetic investigation of Japanese cutaneous melanoma

日本皮肤黑色素瘤的分子遗传学研究

基本信息

  • 批准号:
    09670868
  • 负责人:
  • 金额:
    $ 1.79万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1997
  • 资助国家:
    日本
  • 起止时间:
    1997 至 1999
  • 项目状态:
    已结题

项目摘要

In a systematical analysis in 46 Japnese sporadic primary cutaneous melanomas, we detected loss of heterozygosity (LOH) of chromosome region 9p21 (where the p16 resides) in 11 (24%) tumors. Direct sequencing, however, revealed no somatic mutation of the p16 gene. Further sequencing analyses in 19 additional tumours with no evidence of LOH of 9p21 identified only one heterozygous C->T mutation at codon 81. De novo methylation of the promoter 5'CpG island of the p16 gene, which would lead to transcriptional silencing, was not demonstrated in any of these 12 tumours harboring 9p21 LOH or heterozygous p16 mutation by methylation-specific PCR assay. Nonetheless, complete loss of p16 protein, most likely due to homozygous deletion of the p16 gene, was observed in 6 (15%) out of 39 evaluable cases by immunohistochemical analyses on frozen sections. The results show that inactivation of p16 is not as frequent in primary melanoma as has been reported in cell lines, and warrant further search for another tumour suppressor on 9p21 which is likely to be more important in the initiation of melanoma. Simultaneous investigation examining corresponding metastases in 14 cases showed complete loss of p16 expression during matastatic progression in 4 cases, suggesting that inactivation of p16 plays an important role in progression (rather than initiation) of sporadic melanoma. This analysis also compared LOH of chromosome arms 6q, 9p, 9q, 10q, 11q and 18q, and provided clear evidence that in 3 cases clones of cells found in the sites of metastasis did not derive from the dominant subclone within the primary tumor, indicating that a linear model of melanoma progression is too simplistic, as there is likely to be considerable genetic heterogeneity at the earliest stages of tumourigenesis and that metastases from the same tumor may harbor different genetic change.
在46个Japnese偶发的原发性皮肤黑色素瘤中的系统分析中,我们检测到染色体区域9p21(p16居住)在11(24%)肿瘤中的杂合性丧失(LOH)。然而,直接测序显示没有p16基因的体细胞突变。 Further sequencing analyses in 19 additional tumours with no evidence of LOH of 9p21 identified only one heterozygous C->T mutation at codon 81. De novo methylation of the promoter 5'CpG island of the p16 gene, which would lead to transcriptional silencing, was not demonstrated in any of these 12 tumours harboring 9p21 LOH or heterozygous p16 mutation by methylation-specific PCR分析。尽管如此,在39例可评估病例中,通过对冷冻切片的免疫组织化学分析,在39例可评估病例中观察到了P16蛋白的完全损失,这很可能是由于p16基因的纯合缺失引起的。结果表明,在原发性黑色素瘤中灭活p16的频繁不如细胞系报道,并保证在9p21上进一步寻找另一个肿瘤抑制剂,这对于开始黑色素瘤的结果可能更为重要。在14例病例中检查相应转移的同时研究表明,在4例矩阵进展过程中p16表达完全丧失,这表明p16的失活在零星黑色素瘤的进展(而不是开始)中起重要作用。该分析还比较了染色体臂6q,9p,9q,9q,10q,11q和18q的LOH,并提供了明确的证据,表明在转移部位发现的3例细胞克隆并未从原发性肿瘤中的主要亚克隆中得出,表明黑素瘤的进展很简单,可能是属性的,并且可能是属性的,并且属性是有效的。来自同一肿瘤的转移可能具有不同的遗传变化。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Morita R, Fujimoto A, Hatta N, Takehara K, and Takata M: "Comparison of genetic profiles between primary melanomas and their metastases reveals genetic alterations and clonal evolution during progression"J Invest Dermatol. 111. 919-924 (1998)
Morita R、Fujimoto A、Hatta N、Takehara K 和 Takata M:“原发性黑色素瘤与其转移瘤之间的遗传图谱比较揭示了进展过程中的遗传改变和克隆进化”J Invest Dermatol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takata M,Morita R,Takehara K: "Clonal heterogeneity in sporadic melanoma as revealed by loss of heterozygosity analysis"Int J Cancer. 85. 492-497 (2000)
Takata M、Morita R、Takehara K:“通过杂合性丢失分析揭示散发性黑色素瘤的克隆异质性”Int J Cancer。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Fujimoto A, Morita R, Hatta N, Takehara K, Takata M: "p16ィイD1INK4aィエD1 inactivation is not frequent in uncultured sporadic primary cutaneous melanoma."Oncogene. 18. 2527-2532 (1999)
Fujimoto A、Morita R、Hatta N、Takehara K、Takata M:“p16D1INK4aD1 失活在未培养的散发性原发性皮肤黑色素瘤中并不常见。”Oncogene。18. 2527-2532 (1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takata M, Morita R, Takehara K: "Clonal heterogeneity in sporadic melanomas as revealed by loss-of-heterozygosity analysis."Int J Cancer. 85. 492-497 (2000)
Takata M、Morita R、Takehara K:“杂合性丢失分析揭示了散发性黑色素瘤的克隆异质性。”Int J Cancer。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
高田 実: "皮膚癌の遺伝子異常(3)悪性黒色腫の遺伝子異常" 皮膚科の臨床. 39. 689-694 (1997)
Minoru Takada:“皮肤癌的遗传异常 (3) 恶性黑色素瘤的遗传异常”临床皮肤病学 39. 689-694 (1997)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAKATA Minoru其他文献

TAKATA Minoru的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAKATA Minoru', 18)}}的其他基金

Regulatory mechanisms of CtIP nuclease during DNA crosslink repair
DNA交联修复过程中CtIP核酸酶的调控机制
  • 批准号:
    24310042
  • 财政年份:
    2012
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Regulation of protein expression using a cell cyclce-specific degron and its application to functional analysis
使用细胞周期特异性降解决定子调节蛋白质表达及其在功能分析中的应用
  • 批准号:
    23651046
  • 财政年份:
    2011
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Regulation of the ubiquitin system by checkpoint kinases in response to stalled replication forks
检查点激酶对泛素系统的调节以响应停滞的复制叉
  • 批准号:
    21390094
  • 财政年份:
    2009
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Regulation of the ubiquitin system by checkpoint kinases in response to stalled replication forks
检查点激酶对泛素系统的调节以响应停滞的复制叉
  • 批准号:
    19390087
  • 财政年份:
    2007
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Induction of single DNA double strand break in animal cell genome and its monitoring methodology
动物细胞基因组中单DNA双链断裂的诱导及其监测方法
  • 批准号:
    17590279
  • 财政年份:
    2005
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Functional analysis of Fanconi anemia genes that are involved in chromosomal stability and tumor prevention
涉及染色体稳定性和肿瘤预防的范可尼贫血基因的功能分析
  • 批准号:
    17013083
  • 财政年份:
    2005
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Physical monitoring of repair process of chromosomal double stand break induced by simultaneous nuclear introduction of I-SceI endonuclease
I-SceI核酸内切酶同时入核诱导染色体双链断裂修复过程的物理监测
  • 批准号:
    15590259
  • 财政年份:
    2003
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of new assays to evaluate cellular effects of jonizing radiation
开发新的测定方法来评估琼化辐射的细胞效应
  • 批准号:
    12480155
  • 财政年份:
    2000
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Functional analysis of genes involved in maintenance of chromosome stability and homologous recombination
参与维持染色体稳定性和同源重组的基因的功能分析
  • 批准号:
    12213059
  • 财政年份:
    2000
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas

相似国自然基金

香烟烟雾通过Decorin-PAI-1-p53/p16调控肺泡成纤维细胞衰老在肺气肿的作用及干预研究
  • 批准号:
    82300047
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SMC5-NSMCE2功能异常激活APSCs中p53/p16衰老通路导致脂肪萎缩和胰岛素抵抗的机制研究
  • 批准号:
    82371873
  • 批准年份:
    2023
  • 资助金额:
    50.00 万元
  • 项目类别:
    面上项目
细胞核变形与P16 DNA甲基化协同促进CDKN2A基因拷贝数缺失
  • 批准号:
    82372586
  • 批准年份:
    2023
  • 资助金额:
    46 万元
  • 项目类别:
    面上项目
辐射激活IFN-γ/RGS1/p16信号引起巨噬细胞衰老促进RIPF发生发展的机制研究
  • 批准号:
    82304071
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
Bmal1/p16正反馈环路调控椎间盘退变的机制研究
  • 批准号:
    82372483
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目

相似海外基金

Investigating p16 Loss in Pro-tumorigenic Metabolism
研究促肿瘤代谢中的 p16 丢失
  • 批准号:
    10596462
  • 财政年份:
    2020
  • 资助金额:
    $ 1.79万
  • 项目类别:
Investigating p16 Loss in Pro-tumorigenic Metabolism
研究促肿瘤代谢中的 p16 丢失
  • 批准号:
    9980661
  • 财政年份:
    2020
  • 资助金额:
    $ 1.79万
  • 项目类别:
Investigating p16 Loss in Pro-tumorigenic Metabolism
研究促肿瘤代谢中的 p16 丢失
  • 批准号:
    10312250
  • 财政年份:
    2020
  • 资助金额:
    $ 1.79万
  • 项目类别:
PERSONALIZED THERAPY FOR p16-DEFICIENT MELANOMA
p16 缺乏的黑色素瘤的个性化治疗
  • 批准号:
    9933633
  • 财政年份:
    2018
  • 资助金额:
    $ 1.79万
  • 项目类别:
p16 mechanisms in melanoma
黑色素瘤中的 p16 机制
  • 批准号:
    9178373
  • 财政年份:
    2016
  • 资助金额:
    $ 1.79万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了